Skip to main content

Table 2 Questionnaire Means and Standard Deviations per Treatment Modality Group and Adjusted Standardised Regression Coefficients for Face-to-Face vs. Telepsychiatry Combined

From: Treatment provision for adults with ADHD during the COVID-19 pandemic: an exploratory study on patient and therapist experience with on-site sessions using face masks vs. telepsychiatric sessions

  Face-to-face
(n = 29)
Videoconferencing
(n = 11)
Telephone
(n = 20)
β p
SEQ
 depth 5.50 (0.73) 4.47 (1.07) 5.12 (0.89) −0.49 .001
 smoothness 5.68 (1.02) 5.14 (1.40) 5.49 (1.05) −0.10 .508
 post-session positivity 5.36 (1.12) 5.35 (1.14) 5.44 (0.98) 0.06 .731
CSQ
 total score 3.75 (0.30) 3.63 (0.38) 3.71 (0.30) −0.23 .143
WAI-SR-P
 bond 4.41 (0.51) 4.39 (0.60) 4.21 (0.72) −0.16 .322
 tasks 3.99 (0.52) 3.75 (0.68) 3.78 (0.68) −0.27 .084
 goals 3.95 (0.58) 4.14 (0.49) 3.93 (0.77) 0.08 .612
WAI-SR-T
 bond 4.16 (0.50) 4.30 (0.33) 4.04 (0.53) −0.19 .207
 tasks 3.75 (0.45) 3.93 (0.37) 3.61 (0.50) −0.19 .221
 goals 3.62 (0.47) 3.91 (0.44) 3.53 (0.39) −0.03 .844
  1. Note: The values represent the mean; the standard deviation is reported in brackets. The maximum scores for the SEQ subscales, the WAI-SR subscales, and the CSQ scale are 7, 5, and 4, respectively. The standardized beta coefficient for the predictor treatment modality (face-to-face or telepsychiatry [telephone and videoconferencing combined]; reference group: face-to-face), which is adjusted for therapist and number of sessions, is reported for each outcome variable together with the p value of the regression coefficient